Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Healthcare Biotechnology
Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin... see more

Current News (TSXV:ARCH)

Arch Biopartners Closes Non-Brokered Private Placement

GlobeNewswire November 19, 2025

Arch Biopartners Arranges Non-Brokered Private Placement

GlobeNewswire November 10, 2025

Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia

GlobeNewswire November 5, 2025

Arch Strengthens its Position as a Leading Kidney Therapeutics Company with the Acquisition of a Breakthrough Platform to Develop New Drugs Targeting Chronic Kidney Disease (CKD)

GlobeNewswire September 17, 2025

Arch Biopartners Announces First Patient Successfully Dosed at Toronto General Hospital in Phase II Trial of LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury

GlobeNewswire August 6, 2025

Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)

GlobeNewswire July 22, 2025

Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

GlobeNewswire April 22, 2025

Arch Biopartners Closes Non-Brokered Private Placement

GlobeNewswire March 14, 2025

Arch Biopartners Arranges Non-Brokered Private Placement

GlobeNewswire March 5, 2025
View More News ››

Opinion & Analysis (TSXV:ARCH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:ARCH)

Algo Flip

I would assume we must be very close to the bottom and finished consollidating here at the $1.00. The Algo's have achieved their...
Viking2233 - 6 days ago

Current Share Price

Is there sny bonafide reason(s) why share price should be higher? Absolutely! We have two active phase 2 trials with one trial...
Viking2233 - November 21, 2025

Business Plan

What is the game plan, does Arch have a business plan that will drive buyers into the market?   That is a bonafide question...
Viking2233 - November 14, 2025

New Shareholders or New Management?

I understand that management wants me to sell my shares because I've become a "squeaky wheel" by raising concerns. It'...
TheBearInTheWoods - November 11, 2025

Recent Selloff

So the recent sell off of a couple million shares by desparate shareholder has exposed some cracks in Arch Managements Business Model...
Viking2233 - October 23, 2025

RE:NEW 52 Week Low - Where is Management?

I have held these for quite a long time, and rarely check in. Absolutely shocked at the share price. Is it going bust?
Bertie20 - October 22, 2025
View more Bullboard ››

Mirasol Resources Ltd.

Mirasol Resources Ltd.

Mirasol Resources Ltd. engages in the acquisition and exploration of mineral properties in Chile and Argentina. The company ...
View More »